CAR T Cell Clinical Trials

City of Hope’s comprehensive chimeric antigen receptor (CAR) T cell therapy program is addressing some of the hardest-to-treat cancers by accelerating innovative clinical research approaches.
 
For all CAR T inquiries (patient, physician and clinical trials)
 
Media inquiries
800-888-5323
[email protected]

Ongoing Trials

Ongoing CAR T clinical research initiated at City of Hope includes trials in:

Solid Tumors

Blood Cancers

Partner Trials

City of Hope is partnering with global biopharmaceutical companies on the following ongoing trials:

Solid Tumors

Blood Cancers

New Trials

Blood Cancers

  • The rare disease amyloidosis

Preclinical Research

City of Hope is also conducting preclinical CAR T cell therapy research in solid tumors for ovarian, head and neck, cervical and pancreatic cancers.